PHARMACEUTICAL & BIOTECH PARTNERS
The antiparasitic screening partner built for industry
From validated in vitro assay panels to novel platform development for targets where no established screening exists — ADR Solutions provides the research infrastructure that drug discovery programs need.
View assay catalog ↓
WHY ADR SOLUTIONS
We build what doesn’t exist yet
Pharmaceutical and biotech companies increasingly need validated screening capability beyond the traditional pipeline. Ticks, fleas, exotic species, emerging resistance mechanisms — the biology is complex, the commercial stakes are high, and the assay infrastructure often simply doesn't exist.
ADR Solutions develops these platforms from the ground up, with milestone-based partnership structures designed for pharma timelines and BD requirements.
6+
Parasite species in our screening catalog
AI
Assisted phenotyping for quantitative endpoints
80
Drug conditions screened per plate
1yr
Raw data storage included with every contract
IN VITRO ASSAY CATALOG
Validated assays across six parasite systems
Imaging-based quantitative endpoints with AI-assisted phenotyping. Results delivered in tabular format with R-based visualization and QC overviews. Contact us to discuss your project.
MODEL ORGANISM
C. elegans
Development and motility phenotypes. Synchronized L1 or young adult worms. Up to 80 drug conditions per plate.
Starting point for compound library screening
HEARTWORM
Dirofilaria immitis - Mf
Motility and viability imaging across 24–48hr timepoints. 1,000 microfilariae per well in 96-well format.
Rapid motility and viability readouts
HEARTWORM
Dirofilaria immitis - L3, L4
Motility, molting, and viability. 96-well to 384-well transfer. 24, 48, 72hr timepoints.
Starting point for compound library screening
FILARIAL
Brugia malayi / B. pahangi
Microfilariae, L3/L4, and adult stages. Motility, fecundity, and viability endpoints available.
Multiple life stages available
GI NEMATODE
Haemonchus contortus
Egg hatching, motility, and larval development from sheep-sourced eggs. Up to 168hr tracking.
Sheep-sourced, field-relevant parasite
ECTOPARASITE COMING SOON
Ctenocephalides felis
Adult flea motility assay. Tarsal and sensory assay formats. Consultation required for scoping.
Contact us to discuss
BEYOND THE CATALOG
Building screening where none exists yet
Novel platform development
When your target doesn't have a validated assay, we develop one. Tick species, emerging nematode targets, novel ectoparasites — designed and validated from the ground up with milestone-based delivery.
Genetic & target discovery
Transgenic C. elegans strains, gene knock-outs, parasitization, forward genetic screens, and tissue preparation for drug target engagement assays.
AI-assisted phenotyping pipelines
Bespoke image analysis pipelines for your specific target and phenotype — from camera setup to quantitative output framework compatible with your existing workflows.
WORKING TOGETHER
Custom-scoped for every engagement
Every project is different. We work with pharmaceutical and biotech partners to scope engagements that fit your program — whether that's a single screening plate, a multi-assay campaign, or a multi-year platform development partnership.
All work is performed under confidentiality agreement. We don't share client data, methods, or project details.
THE TEAM
The researchers behind the science
Elyssa Campbell, Ph.D.
Co-Founder & CEO
Research Faculty, UGA College of Veterinary Medicine. Director, Filariasis Research Reagent Resource Center.
Leonor Sicalo Gianechini, DVM, Ph.D., DACVM (Parasitology)
Co-Founder
Assistant Professor, UGA Department of Infectious Diseases. Veterinarian with expertise across livestock, companion animals, and exotic species.
Mostafa Zamanian, Ph.D.
Co-Founder & CTO
Associate Professor, UW–Madison. Expert in helminth genomics, ion channel pharmacology, and AI-driven drug discovery pipelines.
Ready to discuss your screening needs?
Whether you're scoping a single assay plate or a multi-year drug discovery collaboration — we'd like to understand your program. All conversations are confidential.